Form 4 for NUVB Nuvation Bio Inc.
Accepted 2026-06-24 19:07:16 ET · period of report 2026-06-23 · accession 0002039891-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Sauvage Philippe | CFO | M - OptEx | $2.17 | +47.7K | 60.3K | +376% | +$103.4K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Sauvage Philippe | CFO | S - Sale+OE | $6.01 | -47.7K | 12.7K | -79% | -$286.4K |
| DT | 2026-06-24 19:07 | 2026-06-23 | NUVB | Sauvage Philippe | CFO | M - OptEx | $0.00 | -47.7K | 702.3K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-06-23 | M | A | 47,668 | $2.17 | 60,341 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-06-23 | S | D | 47,668 | $6.01 | 12,673 | D | — | — | (F1) Shares sold pursuant to a 10b5-1 plan dated December 4, 2025. (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.04. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-23 | M | D | 47,668 | $0.00 | 702,332 | D | $2.17 · — to 2034-10-06 | 47,668 Class A Common Stock | (F3) Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |